Federal Funding Opportunities March 27th-31st, 2023

March 23, 2023

NIH:

NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional) (PA-23-134) National Institutes of Health Application Receipt Date(s): September 28, 2023
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) (PAR-23-122) National Institute of General Medical Sciences National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Library of Medicine Office of Behavioral and Social Sciences Research Office of the Director, NIH Office of Research on Women’s Health Application Receipt Date(s): May 07, 2026
Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed) (PAR-23-123) National Human Genome Research Institute National Cancer Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): June 01, 2023
Biological Testing Facility (X01 Clinical Trial Not Allowed) (PAR-23-128) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): Multiple dates, see announcement.
Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 – Clinical Trial Not Allowed) (PAR-23-140) National Institute of Neurological Disorders and Stroke National Institute on Aging Application Receipt Date(s): June 02, 2023
Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed) (RFA-AG-24-004) National Institute on Aging Application Receipt Date(s): July 03, 2023
Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional) (RFA-AG-24-009) National Institute on Aging National Institute of Neurological Disorders and Stroke Application Receipt Date(s): July 31, 2023
Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed) (RFA-AG-24-010) National Institute on Aging Application Receipt Date(s): July 02, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed) (RFA-AI-23-019) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): June 08, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed) (RFA-AI-23-020) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): June 08, 2023
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed) (RFA-AI-23-021) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): June 08, 2023
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) (RFA-CA-23-031) National Cancer Institute Application Receipt Date(s): May 05, 2023
NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) (RFA-EB-23-002) National Institute of Biomedical Imaging and Bioengineering Application Receipt Date(s): May 31, 2023
Systematic Review of Clinical Outcome Assessments (COAs) for Communication Brain-Computer Interface Devices (cBCIs) in Amyotrophic Lateral Sclerosis (ALS) (UH2/UH3) Clinical Trials Not Allowed (RFA-FD-23-030) Food and Drug Administration Application Receipt Date(s): May 24, 2023
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (RFA-NS-24-004) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): January 20, 2026
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) (RFA-NS-24-005) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): January 20, 2026
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-23-004) Office of Strategic Coordination (Common Fund) Application Receipt Date(s): September 08, 2023

NIA: